Literature DB >> 20389057

Total and individual coronary artery calcium scores as independent predictors of mortality in hemodialysis patients.

Ronney S Shantouf1, Matthew J Budoff, Naser Ahmadi, Arshia Ghaffari, Ferdinand Flores, Ambarish Gopal, Nazanin Noori, Jennie Jing, Csaba P Kovesdy, Kamyar Kalantar-Zadeh.   

Abstract

Many traditional and nontraditional risk factors contribute to vascular calcification among maintenance hemodialysis (MHD) patients. It is not clear whether coronary artery calcification (CAC) delineates a higher mortality risk independent of known risk factors. We examined 6-year (10/2001-9/2007) survival of 166 MHD patients, aged 53 +/- 13 years, with baseline CAC scores. Patients were grouped into four CAC groups: 0, 1-100, 101-400, and 400+. The 101-400 and 400+ groups were associated with a significantly higher adjusted risk of death than CAC 0 with hazard ratios (HR) 8.5 (95% CI: 1.1-48.1, p = 0.02) and 13.3 (95% CI: 1.3-65.1, p = 0.01), respectively, independent of demographics, comorbidity, lipids and other cardiovascular risks, surrogates of bone disease, nutritional and inflammatory markers and dialysis dose. Total CAC [HR 6.7 (1.1-21.5, p = 0.03)] followed by the presence of CAC in the left main [4.6 (2.2-9.8, p = 0.001)] and left anterior descending artery [4.3 (2.1-14.2, p = 0.001)] were strong independent predictors of mortality even after adjusting for above covariates. Total and vessel-specific CAC predict mortality in MHD patients independent of traditional and nontraditional risk factors. 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20389057      PMCID: PMC2883846          DOI: 10.1159/000294405

Source DB:  PubMed          Journal:  Am J Nephrol        ISSN: 0250-8095            Impact factor:   3.754


  24 in total

Review 1.  Cardiovascular risk in uraemic patients-is it fully explained by classical risk factors?

Authors:  C Zoccali
Journal:  Nephrol Dial Transplant       Date:  2000-04       Impact factor: 5.992

2.  Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients.

Authors:  G A Block; P Raggi; A Bellasi; L Kooienga; D M Spiegel
Journal:  Kidney Int       Date:  2007-01-03       Impact factor: 10.612

Review 3.  The Nutritional and Inflammatory Evaluation in Dialysis patients (NIED) study: overview of the NIED study and the role of dietitians.

Authors:  Sara Colman; Rochelle Bross; Debbie Benner; Joanne Chow; Amy Braglia; Jenia Arzaghi; Jennifer Dennis; Leslie Martinez; Delma Baylon Baldo; Vina Agarwal; Tina Trundnowski; Jennifer Zitterkoph; Brenda Martinez; Osman S Khawar; Kamyar Kalantar-Zadeh
Journal:  J Ren Nutr       Date:  2005-04       Impact factor: 3.655

4.  Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study.

Authors:  G A Block; T E Hulbert-Shearon; N W Levin; F K Port
Journal:  Am J Kidney Dis       Date:  1998-04       Impact factor: 8.860

5.  Ethnic differences in the prognostic value of coronary artery calcification for all-cause mortality.

Authors:  Khurram Nasir; Leslee J Shaw; Sandy T Liu; Steven R Weinstein; Tristen R Mosler; Phillip R Flores; Ferdinand R Flores; Paolo Raggi; Daniel S Berman; Roger S Blumenthal; Matthew J Budoff
Journal:  J Am Coll Cardiol       Date:  2007-08-20       Impact factor: 24.094

6.  Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein.

Authors:  Paul M Ridker; Eleanor Danielson; Francisco A H Fonseca; Jacques Genest; Antonio M Gotto; John J P Kastelein; Wolfgang Koenig; Peter Libby; Alberto J Lorenzatti; Jean G MacFadyen; Børge G Nordestgaard; James Shepherd; James T Willerson; Robert J Glynn
Journal:  N Engl J Med       Date:  2008-11-09       Impact factor: 91.245

Review 7.  The scope of coronary heart disease in patients with chronic kidney disease.

Authors:  Fadi G Hage; Rajesh Venkataraman; Gilbert J Zoghbi; Gilbert J Perry; Angelo M DeMattos; Ami E Iskandrian
Journal:  J Am Coll Cardiol       Date:  2009-06-09       Impact factor: 24.094

8.  Long-term prognosis associated with coronary calcification: observations from a registry of 25,253 patients.

Authors:  Matthew J Budoff; Leslee J Shaw; Sandy T Liu; Steven R Weinstein; Tristen P Mosler; Philip H Tseng; Ferdinand R Flores; Tracy Q Callister; Paolo Raggi; Daniel S Berman
Journal:  J Am Coll Cardiol       Date:  2007-04-20       Impact factor: 24.094

9.  Chronic peritoneal dialysis in the United States: declining utilization despite improving outcomes.

Authors:  Rajnish Mehrotra; Dulcie Kermah; Linda Fried; Kamyar Kalantar-Zadeh; Osman Khawar; Keith Norris; Allen Nissenson
Journal:  J Am Soc Nephrol       Date:  2007-09-05       Impact factor: 10.121

10.  Coronary calcium as a predictor of coronary events in four racial or ethnic groups.

Authors:  Robert Detrano; Alan D Guerci; J Jeffrey Carr; Diane E Bild; Gregory Burke; Aaron R Folsom; Kiang Liu; Steven Shea; Moyses Szklo; David A Bluemke; Daniel H O'Leary; Russell Tracy; Karol Watson; Nathan D Wong; Richard A Kronmal
Journal:  N Engl J Med       Date:  2008-03-27       Impact factor: 91.245

View more
  51 in total

1.  Association of cumulatively low or high serum calcium levels with mortality in long-term hemodialysis patients.

Authors:  Jessica E Miller; Csaba P Kovesdy; Keith C Norris; Rajnish Mehrotra; Allen R Nissenson; Joel D Kopple; Kamyar Kalantar-Zadeh
Journal:  Am J Nephrol       Date:  2010-09-03       Impact factor: 3.754

2.  Dietary egg whites for phosphorus control in maintenance haemodialysis patients: a pilot study.

Authors:  Lynn M Taylor; Kamyar Kalantar-Zadeh; Theodore Markewich; Sara Colman; Debbie Benner; John J Sim; Csaba P Kovesdy
Journal:  J Ren Care       Date:  2011-03

Review 3.  Dietary restrictions in dialysis patients: is there anything left to eat?

Authors:  Kamyar Kalantar-Zadeh; Amanda R Tortorici; Joline L T Chen; Mohammad Kamgar; Wei-Ling Lau; Hamid Moradi; Connie M Rhee; Elani Streja; Csaba P Kovesdy
Journal:  Semin Dial       Date:  2015-02-03       Impact factor: 3.455

4.  Examining associations of circulating endotoxin with nutritional status, inflammation, and mortality in hemodialysis patients.

Authors:  Usama Feroze; Kamyar Kalantar-Zadeh; Kevin A Sterling; Miklos Z Molnar; Nazanin Noori; Debbie Benner; Vallabh Shah; Rama Dwivedi; Kenneth Becker; Csaba P Kovesdy; Dominic S Raj
Journal:  J Ren Nutr       Date:  2011-08-31       Impact factor: 3.655

5.  A phase 1b randomized, placebo-controlled clinical trial with SNF472 in haemodialysis patients.

Authors:  Carolina Salcedo; Pieter H Joubert; Miguel D Ferrer; Ana Z Canals; Francisco Maduell; Vicens Torregrosa; Josep Maria Campistol; Raquel Ojeda; Joan Perelló
Journal:  Br J Clin Pharmacol       Date:  2019-02-19       Impact factor: 4.335

Review 6.  Cardiac imaging in patients with chronic kidney disease.

Authors:  Diana Y Y Chiu; Darren Green; Nik Abidin; Smeeta Sinha; Philip A Kalra
Journal:  Nat Rev Nephrol       Date:  2015-01-06       Impact factor: 28.314

7.  Deoxycholic Acid, a Metabolite of Circulating Bile Acids, and Coronary Artery Vascular Calcification in CKD.

Authors:  Anna Jovanovich; Tamara Isakova; Geoffrey Block; Jason Stubbs; Gerard Smits; Michel Chonchol; Makoto Miyazaki
Journal:  Am J Kidney Dis       Date:  2017-08-09       Impact factor: 8.860

Review 8.  Coronary artery calcification in chronic kidney disease: An update.

Authors:  Tomasz Stompór
Journal:  World J Cardiol       Date:  2014-04-26

9.  First-time-in-human randomized clinical trial in healthy volunteers and haemodialysis patients with SNF472, a novel inhibitor of vascular calcification.

Authors:  J Perelló; P H Joubert; M D Ferrer; A Z Canals; S Sinha; C Salcedo
Journal:  Br J Clin Pharmacol       Date:  2018-10-03       Impact factor: 4.335

Review 10.  Thyroid functional disease: an under-recognized cardiovascular risk factor in kidney disease patients.

Authors:  Connie M Rhee; Gregory A Brent; Csaba P Kovesdy; Offie P Soldin; Danh Nguyen; Matthew J Budoff; Steven M Brunelli; Kamyar Kalantar-Zadeh
Journal:  Nephrol Dial Transplant       Date:  2014-02-25       Impact factor: 5.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.